ArticleAddictive behaviors reports2018
Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes.
Article in Addictive behaviors reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 1 synthesis or guideline pooled it.
- High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies.The American journal of psychiatry · 2025Pooled it
- Is toke cheap? Correspondence between cannabis demand and purchase in the laboratory.Addiction (Abingdon, England) · 2026Article
- Standardizing Recreational Cannabis Excise Tax Rates in the United States: New Retail Price-Based Measurements by Product Category.International journal of environmental research and public health · 2026Article
- Reactivity to electronic nicotine delivery system (ENDS) cues in adults who smoke cigarettes and vape cannabis.Addictive behaviors · 2026Article
- Prevalence and trends in cannabis use disorder and cannabis poisoning among Medicaid enrollees: a multistate analysis, 2011-2022.Health affairs scholar · 2025Article
- Cannabis administration is associated with reduced alcohol consumption: Evidence from a novel laboratory co-administration paradigm.Drug and alcohol dependence · 2025Article
- Accuracy of labeled THC potency across flower and concentrate cannabis products.Scientific reports · 2025Article
- Pain Intensity and Hazardous Cannabis Use: The Moderating Role of Pain-related Anxiety.Journal of psychoactive drugs · 2025Article
- Modes of cannabis use, frequency of use, and cannabis use problems: A latent profile analysis of modes of cannabis use.Addictive behaviors · 2025Article
- Comorbid Cannabis Use and Mood Disorders Among Adolescents.Focus (American Psychiatric Publishing) · 2025Review
- Cannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adults.Substance abuse treatment, prevention, and policy · 2025Article
- Risk assessment of metals measured in regulated Canadian dried cannabis and cannabis vaping products: case study and perspectives.Frontiers in toxicology · 2025Article
- Cannabis Products and Use Patterns Associated with Cannabis Use Disorder Symptoms Among Youth in Southern California.Cannabis (Albuquerque, N.M.) · 2025Article
- Beyond Frequency and Quantity of Cannabis Consumption Among College Students: Context of Using Cannabis Relates to Cannabis-Related Outcomes.Cannabis (Albuquerque, N.M.) · 2025Article
- Cannabis use disorder: from neurobiology to treatment.The Journal of clinical investigation · 2024Review
- Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.Cannabis and cannabinoid research · 2024Article
- Probing the Paradox: Investigating the Impact of Affect, Exercise Type, and Cannabis Use on the Alcohol-Exercise Relationship in College Students.International journal of exercise science · 2024Article
- Article
- ΔCardiovascular toxicology · 2023Article
- Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.Experimental and clinical psychopharmacology · 2023Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConcentrated cannabis products are increasingly available and used, particularly in states with legal cannabis, but little is known about the profiles and characteristics of concentrate users. We aimed to characterize user profiles of cannabis users living in states with legal medical or recreational cannabis who reported using concentrates to those who do not use concentrates.
methodsAn anonymous online survey was advertised in California, Colorado, Nevada, Oregon, and Washington. We compared respondents who endorsed frequent concentrate use (FC; N = 67) (i.e. 4 days/week) with cannabis users who never use concentrates (NC; N = 64), and with those who smoke/vaporize cannabis flower frequently but never or very rarely use concentrates (FF; N = 60), on measures related to cannabis use patterns and cannabinoid product strength, other substance use, and occupational functioning and health.
resultsFC endorsed more symptoms of cannabis use disorder as compared to non-concentrate users (
conclusionsConcentrate users endorsed higher symptoms of cannabis use disorder and use higher strength cannabis even when using non-concentrated forms. Frequent use of concentrates may be associated with additional risks over and above frequent use of flower forms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.